Related Experiment Video
Updated: Jul 10, 2026
09:39
Creation of Reversible Cholestatic Rat Model
Published on: May 21, 2011
[Cholestasis of pregnancy]
Sara Lorente1, Miguel A Montoro
1Unidad de Gastroenterología y Hepatología. Hospital San Jorge de Huesca. Huesca. España. slorente@salud.aragon.es
Gastroenterologia Y Hepatologia
|November 6, 2007
Summary
Intrahepatic cholestasis of pregnancy (ICP) causes itching and liver issues during pregnancy. Ursodeoxycholic acid effectively treats ICP, improving symptoms and liver tests without harming mother or fetus.
Area of Science:
- Hepatology
- Obstetrics and Gynecology
- Perinatology
Background:
- Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-specific liver condition characterized by pruritus and cholestasis.
- It typically manifests in the second or third trimester and resolves post-delivery.
- ICP is associated with potential fetal complications, including distress and increased perinatal mortality.
Purpose of the Study:
- To review the pathogenesis, clinical presentation, and management of intrahepatic cholestasis of pregnancy.
- To evaluate the efficacy and safety of ursodeoxycholic acid as a treatment for ICP.
Main Methods:
- Review of existing literature on intrahepatic cholestasis of pregnancy.
- Analysis of clinical data regarding ICP presentation and laboratory findings.
- Evaluation of treatment outcomes for various therapeutic agents, focusing on ursodeoxycholic acid.
Main Results:
- ICP presents with pruritus and elevated serum bile salts and aminotransferases.
- Pathogenesis is multifactorial, involving genetic predisposition, hormonal influences, and environmental factors.
- Ursodeoxycholic acid demonstrates significant improvement in pruritus and liver function tests.
Conclusions:
- Ursodeoxycholic acid is the most effective treatment for ICP, showing no maternal or fetal toxicity.
- ICP management should focus on symptomatic relief and prevention of fetal complications.
- Further research into ICP pathogenesis may reveal novel therapeutic targets.
More Related Videos
Related Concept Videos
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:19Ascites
DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:22Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...